Stay updated on PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page.

Latest updates to the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.3.4; Removed Revision: v3.3.3.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe study locations were expanded to include numerous new sites across the U.S. and internationally, and several location groupings were removed.SummaryDifference2%

- Check62 days agoChange DetectedPublications section now states that items are automatically populated from PubMed and may not pertain to the study, and the page revision label has been updated to v3.3.2.SummaryDifference0.1%

- Check69 days agoChange DetectedRemoval of the government funding/operating-status notice from the page. This does not affect the study details, eligibility criteria, or endpoints presented in the ClinicalTrials.gov record.SummaryDifference0.2%

- Check83 days agoChange DetectedNo significant changes detected on the page. Content and layout appear unchanged.SummaryDifference0.2%

- Check112 days agoChange DetectedThe page is updated to announce a funding-related operating status notice and to indicate a new version (v3.2.0), replacing the old v3.1.0.SummaryDifference1%

Stay in the know with updates to PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page.